François Villeret

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Clinical Practice

Prognostic Factors

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

François Villeret, Pierre Nahon
Atezolizumab and bevacizumab with anticoagulant or antiplatelet therapy in hepatocellular carcinoma patients: Real-world data for informed clinical decision-making. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Barbara Testoni, Caroline Scholtès, Marie-Laure Plissonnier, Alexia Paturel, Françoise Berby, Floriana Facchetti, François Villeret, Elisabetta Degasperi, Beth Scott, Aaron Hamilton, Marintha Heil, Pietro Lampertico, Massimo Levrero, Fabien Zoulim
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B. Gut (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Domitille Erard, François Villeret, Yasmina Chouik, Olivier Guillaud, Jean-Yves Scoazec, Cyrielle Caussy, Emmanuel Disse, Olivier Boillot, Valérie Hervieu, Jérôme Dumortier
Dual alcohol and metabolic-related liver disease: Results from a population of liver transplant patients. Liver international : official journal of the International Association for the Study of the Liver (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
François Villeret, Jérôme Dumortier
Response to 'Predictors of mid-term survival after liver transplantation in patients with NAFLD cirrhosis'. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
François Villeret, Sébastien Dharancy, Domitille Erard, Armand Abergel, Louise Barbier, Camille Besch, Olivier Boillot, Karim Boudjema, Audrey Coilly, Filomena Conti, Christophe Corpechot, Christophe Duvoux, François Faitot, Stéphanie Faure, Claire Francoz, Emiliano Giostra, Jean Gugenheim, Jean Hardwigsen, Marie-Noëlle Hilleret, Jean-Baptiste Hiriart, Pauline Houssel-Debry, Nassim Kamar, Guillaume Lassailly, Marianne Latournerie, Georges Philippe Pageaux, Didier Samuel, Claire Vanlemmens, Faouzi Saliba, Jérôme Dumortier
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival. Liver international : official journal of the International Association for the Study of the Liver 42 (11) (2022)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: how does underlying liver disease influence therapeutic strategy and outcomes ? Liver international : official journal of the International Association for the Study of the Liver (2022)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver (2022)